Ironwood Pharmaceuticals (IRWD) Asset Utilization Ratio (2011 - 2026)

Ironwood Pharmaceuticals has disclosed Asset Utilization Ratio across 16 years of filings, most recently posting 0.87 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.87, down 7.19% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.87 (down 7.19% YoY), and the FY2025 annual result was 0.79, down 7.37% from the prior year.
• Asset Utilization Ratio came in at 0.87 for Q1 2026 at Ironwood Pharmaceuticals, up from 0.75 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.96 in Q3 2024 to a low of 0.37 in Q1 2023.
• The 5-year median for Asset Utilization Ratio is 0.87 (2026), against an average of 0.72.
• Across the five-year window, Asset Utilization Ratio slumped 44.42% in 2022 and soared 145.79% in 2024, its largest moves.
• Ironwood Pharmaceuticals' Asset Utilization Ratio stood at 0.38 in 2022, then jumped by 131.97% to 0.89 in 2023, then climbed by 6.68% to 0.95 in 2024, then retreated by 21.31% to 0.75 in 2025, then advanced by 16.42% to 0.87 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.87 (Q1 2026), 0.75 (Q4 2025), and 0.92 (Q3 2025), per Business Quant data.